Related references
Note: Only part of the references are listed.Topological data analysis reveals genotype-phenotype relationships in primary ciliary dyskinesia
Amelia Shoemark et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Developing DMD therapeutics: a review of the effectiveness of small molecules, stop-codon readthrough, dystrophin gene replacement, and exon-skipping therapies
Omar Sheikh et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)
Motile cilia and airway disease
Marie Legendre et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2021)
Defects in the cytoplasmic assembly of axonemal dynein arms cause morphological abnormalities and dysmotility in sperm cells leading to male infertility
Isabella Aprea et al.
PLOS GENETICS (2021)
Primary ciliary dyskinesia in the genomics age
Jane S. Lucas et al.
LANCET RESPIRATORY MEDICINE (2020)
International consensus guideline for reporting transmission electron microscopy results in the diagnosis of primary ciliary dyskinesia (BEAT PCD TEM Criteria)
Amelia Shoemark et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: The international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF)
M. W. Konstan et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
Environmental pollutants damage airway epithelial cell cilia: Implications for the prevention of obstructive lung diseases
Yu Cao et al.
THORACIC CANCER (2020)
Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides
Jamie R. Wangen et al.
ELIFE (2020)
Pharmacological approaches for targeting cystic fibrosis nonsense mutations
Jyoti Sharma et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Effect of Ataluren on dystrophin mutations
Joachim Berger et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
A Revised Protocol for Culture of Airway Epithelial Cells as a Diagnostic Tool for Primary Ciliary Dyskinesia
Janice L. Coles et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Deciphering the Nonsense Readthrough Mechanism of Action of Ataluren: An in Silico Compared Study
Marco Tutone et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Transcriptomic response of primary human airway epithelial cells to flavoring chemicals in electronic cigarettes
Hae-Ryung Park et al.
SCIENTIFIC REPORTS (2019)
Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons
Maciej Dabrowski et al.
MOLECULAR MEDICINE (2018)
The international primary ciliary dyskinesia cohort (iPCD Cohort): methods and first results
Myrofora Goutaki et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia
Jane S. Lucas et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Motile and non-motile cilia in human pathology: from function to phenotypes
Hannah M. Mitchison et al.
JOURNAL OF PATHOLOGY (2017)
Infertility in an adult cohort with primary ciliary dyskinesia: phenotype-gene association
Gert Jan Vanaken et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa
Velina S. Atanasova et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Craig M. McDonald et al.
LANCET (2017)
Avoidance of reporter assay distortions from fused dual reporters
Gary Loughran et al.
RNA (2017)
Amlexanox, a selective inhibitor of IKBKE, generates anti-tumoral effects by disrupting the Hippo pathway in human glioblastoma cell lines
Yang Liu et al.
CELL DEATH & DISEASE (2017)
A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents
Michal Caspi et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations
Venkateshwar Mutyam et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs)
Kerstin Nagel-Wolfrum et al.
BIODRUGS (2016)
Gene editing of DNAH11 restores normal cilia motility in primary ciliary dyskinesia
Michele Lai et al.
JOURNAL OF MEDICAL GENETICS (2016)
Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression
Bijoyita Roy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Aminoglycoside-stimulated readthrough of premature termination codons in selected genes involved in primary ciliary dyskinesia
Zuzanna Bukowy-Bieryllo et al.
RNA BIOLOGY (2016)
Automated time-lapse analysis of ciliary function
Claire Jackson et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Translational readthrough potential of natural termination codons in eucaryotes - The impact of RNA sequence
Maciej Dabrowski et al.
RNA BIOLOGY (2015)
Ciliary dyskinesia is an early feature of respiratory syncytial virus infection
Claire M. Smith et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Restoring ciliary function to differentiated primary ciliary dyskinesia cells with a lentiviral vector
L. E. Ostrowski et al.
GENE THERAPY (2014)
ATALUREN TREATMENT OF PATIENTS WITH NONSENSE MUTATION DYSTROPHINOPATHY
Katharine Bushby et al.
MUSCLE & NERVE (2014)
Evidence of efficient stop codon readthrough in four mammalian genes
Gary Loughran et al.
NUCLEIC ACIDS RESEARCH (2014)
Molecular basis for erythromycin-dependent ribosome stalling during translation of the ErmBL leader peptide
Stefan Arenz et al.
NATURE COMMUNICATIONS (2014)
Mutations in SPAG1 Cause Primary Ciliary Dyskinesia Associated with Defective Outer and Inner Dynein Arms
Michael R. Knowles et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Analysis of a read-through promoting compound in a severe mouse model of spinal muscular atrophy
Virginia B. Mattis et al.
NEUROSCIENCE LETTERS (2012)
Rescue of nonsense mutations by amlexanox in human cells
Sara Gonzalez-Hilarion et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Pharmaceutical therapies to recode nonsense mutations in inherited diseases
Hui-Ling Rose Lee et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons
Alona Zilberberg et al.
GUT (2010)
Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124
Douglas S. Auld et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A comprehensive analysis of translational missense errors in the yeast Saccharomyces cerevisiae
Emily B. Kramer et al.
RNA (2010)
Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model
Virginia B. Mattis et al.
HUMAN MOLECULAR GENETICS (2009)
Nonaminoglycoside compounds induce readthrough of nonsense mutations
Liutao Du et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Ciliary Beating Recovery in Deficient Human Airway Epithelial Cells after Lentivirus Ex Vivo Gene Therapy
Brigitte Chhin et al.
PLOS GENETICS (2009)
Flexible computational docking studies of new aminoglycosides targeting RNA 16S bacterial ribosome site
Florent Barbault et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
A meta-analysis of nonsense mutations causing human genetic disease
Matthew Mort et al.
HUMAN MUTATION (2008)
Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
Eitan Kerem et al.
LANCET (2008)
Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity
Sven N. Hobbie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers
Samit Hirawat et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts
Virginia B. Mattis et al.
HUMAN GENETICS (2006)
Discrimination between defects in elongation fidelity and termination efficiency insights into translational provides mechanistic readthrough
J Salas-Marco et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Effects of a number of classes of 50S inhibitors on stop codon readthrough during protein synthesis
J Thompson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Pyranmycins, a novel class of aminoglycosides with improved acid stability: The SAR of D-pyranoses on ring III of pyranmycin
CWT Chang et al.
ORGANIC LETTERS (2002)
Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system
M Manuvakhova et al.
RNA (2000)
Share Paper
